Published by ChinaMNC · Qichun

China’s New Calibration Standard for Urine Meters: What Foreign Medtech Founders Should Know

China’s market regulator has issued a national metrology standard for urine meters used in intensive care. The rule sets three evaluation dimensions and links manufacturers, hospitals, and regulators. Foreign founders in medical devices should understand how it affects product design, hospital adoption, and compliance in China.

China Issues New National Calibration Standard for Urine Meters

On 27 October 2026, China’s State Administration for Market Regulation (SAMR) released a national metrology technical specification titled Calibration Specification for Urine Meters. The measure is intended to fill a technical gap in the calibration of urine meters in China and to strengthen metrological supervision in critical-care medical settings. For foreign founders active in medical devices, hospital operations, or health-tech in China, the new specification signals how regulators are tightening oversight of clinical measurement equipment—and what that means for product design, market access, and ongoing compliance.

Why Urine Meters Matter in Critical Care

Urine output is a core indicator for assessing a critically ill patient’s circulation and kidney function. Urine meters are essential bedside monitoring devices in intensive care units (ICUs). They continuously collect and record patient urine data, and doctors rely on that information to judge a patient’s condition and adjust treatment plans. If the measurement is inaccurate, it can easily lead to a misjudgment of the patient’s condition and directly endanger the safety of critically ill patients. The new specification therefore focuses on the performance dimensions that matter most for clinical reliability.

Three Evaluation Dimensions Under the Specification

The Calibration Specification for Urine Meters sets out three key metrological evaluation dimensions:

• Alarm function: Ensures the device can promptly trigger audible and visual alarms when urine output is too high, too low, or when intermittent urine output exceeds a preset threshold. This helps medical staff quickly identify abnormal changes in a patient’s condition.
• Accuracy of total urine output indication: Assesses the device’s measurement performance for cumulative urine volume over a specified period. The goal is to ensure stable and reliable data during long-term continuous monitoring scenarios.
• Accuracy of intermittent urine output indication: Assesses the device’s measurement performance for cumulative urine volume within intermittent periods. This ensures that real-time displayed or output urine data is accurate and traceable, providing solid and credible data support for clinical diagnosis.

These dimensions are not merely technical details; they define what regulators and hospitals will expect from urine meters used in critical care. Foreign founders whose products fall within this category should review whether their devices meet these performance expectations and whether their calibration and quality-control processes can demonstrate compliance.

Connecting Industry, Hospitals, and Regulators

Once implemented, the specification is designed to connect three links: industry, medical institutions, and metrological supervision.

For Manufacturers (Industry Link)

The specification guides manufacturers to optimize product design against actual clinical working conditions and to strengthen metrological performance control at the factory. For foreign founders manufacturing or importing urine meters into China, this means that design choices and factory calibration procedures should align with the clinical scenarios in which the device will be used. It also reinforces the importance of documenting metrological performance before products leave the factory.

For Hospitals (Use Link)

The specification guides medical institutions to establish a periodic traceability mechanism for urine meters. It also aims to reinforce the primary responsibility of medical units and to ensure daily metrological control of equipment in use. Foreign founders selling to Chinese hospitals or partnering with healthcare providers should anticipate that hospitals will increasingly ask for calibration and traceability documentation as part of procurement and routine maintenance.

For Regulators (Supervision Link)

The specification provides authoritative technical grounds for market regulation departments to conduct metrological supervision and inspection of medical equipment. It supports full-chain metrological supervision of critical-care equipment from production to clinical use. This means that foreign founders operating in China may face inspections or requests for evidence that their devices comply with the new calibration specification.

Practical Implications for Foreign Founders

For foreign founders registering or operating a company in China, the new specification is a reminder that China’s regulatory environment for medical devices extends beyond product registration. Metrological supervision is a distinct layer of oversight that can affect product design, hospital acceptance, and post-market surveillance. Founders should consider the following practical steps:

• Review product design and calibration procedures: Ensure that alarm functions, total urine output accuracy, and intermittent urine output accuracy are addressed in design and factory testing.
• Prepare documentation: Maintain clear records of calibration methods and performance data that can be shared with hospitals and regulators if requested.
• Engage with hospital partners: Discuss periodic traceability requirements early, as hospitals may build these into procurement contracts and maintenance schedules.
• Monitor implementation: Although the specification has been released, foreign founders should track how local market regulation departments apply it in inspections and what guidance emerges for industry.

These steps are not legal requirements imposed directly on foreign founders by the source text, but they follow from the specification’s stated goals and the three-link approach. Founders should seek local professional advice on how the specification applies to their specific products and operations.

What the Specification Does Not Cover

The source text does not provide details on transition periods, penalties for non-compliance, or specific testing methods. It also does not state whether the specification applies retroactively to devices already in use. Foreign founders should consult the full text of the specification and any implementing guidance from Chinese authorities for such details.

Conclusion

China’s new calibration specification for urine meters is a targeted measure to improve the reliability of critical-care monitoring equipment. For foreign founders in the medical device sector, it highlights the importance of metrological performance and traceability in the Chinese market. By aligning product design, documentation, and hospital engagement with the three evaluation dimensions, founders can better position themselves for compliance and adoption in China’s healthcare system.

This summary is based on information published by the relevant Chinese government website and is general information, not legal or tax advice.

Foreign founders can contact ChinaMNC on WhatsApp / WeChat at +86 153 1898 8535 for help registering and operating a company in China.